Chimeric antigen receptor T cells: a novel therapy for solid tumors

The chimeric antigen receptor T (CAR-T) cell therapy is a newly developed adoptive antitumor treatment. Theoretically, CAR-T cells can specifically localize and eliminate tumor cells by interacting with the tumor-associated antigens (TAAs) expressing on tumor cell surface. Current studies demonstrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shengnan, Li, Anping, Liu, Qian, Li, Tengfei, Yuan, Xun, Han, Xinwei, Wu, Kongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372296/
https://www.ncbi.nlm.nih.gov/pubmed/28356156
http://dx.doi.org/10.1186/s13045-017-0444-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372296/
https://www.ncbi.nlm.nih.gov/pubmed/28356156
http://dx.doi.org/10.1186/s13045-017-0444-9

Ejemplares similares